Overview
No overview information available.
Indication
外用于治疗由皮肤癣菌如红色毛癣菌、须癣毛癣菌。絮状表皮癣菌和犬小孢子菌等所致的浅表皮肤真菌感染，如手癣、足癣（尤其是角化增厚型）、体癣、股癣；亦可用于头癣；也适用于治疗甲真菌病。外用于由念珠菌如白色念珠菌等所致的皮肤念珠菌感染和念珠菌性外阴阴道炎。外用于由马拉色菌属所致的花斑癣。
Associated Conditions
No associated conditions information available.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2009/10/07 | Phase 1 | Completed |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| E. Fougera & Co. a division of Fougera Pharmaceuticals Inc. | 0168-0314 | TOPICAL | 7.7 mg in 1 mL | 8/15/2014 | |
| Bryant Ranch Prepack | 63629-8624 | TOPICAL | 7.7 mg in 1 g | 7/17/2023 | |
| Bryant Ranch Prepack | 63629-8626 | TOPICAL | 7.7 mg in 1 g | 7/17/2023 | |
| Bryant Ranch Prepack | 72162-1397 | TOPICAL | 7.7 mg in 1 g | 3/12/2024 | |
| Leading Pharma, LLC | 69315-309 | TOPICAL | 7.7 mg in 1 mL | 4/30/2020 | |
| Glenmark Pharmaceuticals Inc., USA | 68462-297 | TOPICAL | 7.7 mg in 1 g | 8/31/2019 | |
| Dispensing Solutions, Inc. | 68258-3996 | TOPICAL | 7.7 mg in 1 g | 2/14/2012 | |
| Advanced Rx Pharmacy of Tennessee, LLC | 80425-0225 | TOPICAL | 7.7 mg in 1 g | 1/9/2023 | |
| Bryant Ranch Prepack | 63629-8625 | TOPICAL | 7.7 mg in 1 g | 7/17/2023 | |
| Physicians Total Care, Inc. | 54868-5270 | TOPICAL | 7.7 mg in 1 g | 2/19/2013 |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| No NMPA approvals found for this drug. | |||||
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||
Health Canada Drug Approvals
Approved Product | Company | DIN | Dosage Form | Strength | Market Date |
|---|---|---|---|---|---|
| LOPROX CREAM 1% | hoechst roussel canada inc. | 01987569 | Cream - Topical | 10 MG / G | 12/31/1994 |
| LOPROX | bausch health, canada inc. | 02221802 | Cream - Topical | 1 % / W/W | 12/3/1996 |
| LOPROX LOTION 1.0% | hoechst roussel canada inc. | 01989626 | Lotion - Topical | 1 % | 12/31/1995 |
| LOPROX LOTION 1% | hoechst canada inc. | 00836281 | Lotion - Topical | 10 MG / G | 12/31/1990 |
| LOPROX CRM 1% | hoechst canada inc. | 00593362 | Cream - Topical | 10 MG / G | 12/31/1985 |
| LOPROX | bausch health, canada inc. | 02221810 | Lotion - Topical | 1 % / W/W | 3/24/1997 |
| STIEPROX SHAMPOO | 02247228 | Shampoo - Topical | 1.5 % | 11/17/2003 |
CIMA AEMPS Drug Approvals
Approved Product | Company | Registration Number | Pharmaceutical Form | Prescription Type | Status |
|---|---|---|---|---|---|
| No CIMA AEMPS (Spain) approvals found for this drug. | |||||
Philippines FDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Philippines FDA approvals found for this drug. | |||||
Saudi SFDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Saudi SFDA approvals found for this drug. | |||||
Malaysia NPRA Drug Approvals
Approved Product | Company | Registration Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Malaysia NPRA approvals found for this drug. | |||||
UK EMC Drug Information
Medicine Name | MA Holder | MA Number | Pharmaceutical Form | Active Ingredient | Authorization Date |
|---|---|---|---|---|---|
| No UK EMC drug information found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.